等待开盘 09-20 09:30:00 美东时间
-0.010
-0.11%
An announcement from Ocular Therapeutix (OCUL) is now available. Ocular Therape...
09-03 20:28
Shares of Ocular Therapeutix (NASDAQ:OCUL) rose 6% Wednesday after the company said the FDA has determined that its Phase 3 SOL-R clinical trial is appropriate as a registrational study to support pot...
08-07 23:31
Ocular Therapeutix press release (NASDAQ:OCUL): Q2 GAAP EPS of -$0.26 misses by $0.04. Revenue of $16.44M (+8.2% Y/Y) beats by $0.59M. More on Ocular Therapeutix Ocular Therapeutix: A Speculative Inve...
08-07 19:15
SOL-R AXPAXLI Repeat Dosing Study in Wet AMD Acceptable to FDA as Registrationa...
08-07 19:10
Ocular Therapeutix Inc - Cash Balance Expected to Fund Operations Into 2028
08-07 19:10
Ocular Therapeutix (NASDAQ:OCUL) is scheduled to announce Q2 earnings results on Wednesday, August 7th, before market open. The consensus EPS Estimate is -$0.21 (+19.2% Y/Y) and the consensus Revenue ...
08-07 00:11
观点网讯:6月24日,京基智慧文化发布公告宣布,公司已于香港完成公司名称更改登记,新名称为“Allegro Culture Limited律齐文化有限公司”,并...
06-24 22:19
Quite a few Ocular Therapeutix, Inc. (NASDAQ:OCUL) insiders sold their shares o...
06-23 20:46
Biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) recently announced e...
06-21 10:59
Top Wall Street analysts changed their outlook on these top names. For a comple...
06-20 20:11